DNA Binding to Proteolytically Activated TLR9 is Sequence-independent and Enhanced by DNA Curvature

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2012 Jan 20

PMID 22258621

Citations 38

Authors

Yue Li

Ian C Berke

Yorgo Modis

Affiliations

Soon will be listed here.

Abstract

Toll-like receptor 9 (TLR9) recognizes microbial DNA in endolysosomal compartments. The ectodomain of TLR9 must be proteolytically cleaved by endosomal proteases to produce the active receptor capable of inducing an innate immune signal. We show that the cleaved TLR9 ectodomain is a monomer in solution and that DNA ligands with phosphodiester backbones induce TLR9 dimerization in a sequence-independent manner. Ligands with phosphorothioate (PS) backbones induce the formation of large TLR9-DNA aggregates, possibly due to the propensity of PS ligands to self-associate. DNA curvature-inducing proteins including high-mobility group box 1 and histones H2A and H2B significantly enhance TLR9 binding, suggesting that TLR9 preferentially recognizes curved DNA backbones. Our work sheds light on the molecular mechanism of TLR9 activation by endogenous protein-nucleic acid complexes, which are associated with autoimmune diseases including systemic lupus erythematosus.

Citing Articles

The Role of Breast Milk Cell-Free DNA in the Regulation of the Neonatal Immune Response.

Rezai T, Fell-Hakai S, Guleria S, Toldi G Nutrients. 2025; 16(24.

PMID: 39770994 PMC: 11678730. DOI: 10.3390/nu16244373.

Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles.

Liu X, Chen S, Huang J, Du Y, Luo Z, Zhang Y Nat Nanotechnol. 2024; 19(11):1745-1756.

PMID: 39160338 DOI: 10.1038/s41565-024-01759-2.

Targeting Neutrophil Extracellular Traps in Gouty Arthritis: Insights into Pathogenesis and Therapeutic Potential.

Li C, Wu C, Li F, Xu W, Zhang X, Huang Y J Inflamm Res. 2024; 17:1735-1763.

PMID: 38523684 PMC: 10960513. DOI: 10.2147/JIR.S460333.

Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints.

Chen Q, Chuai G, Zhang H, Tang J, Duan L, Guan H Nat Commun. 2023; 14(1):7521.

PMID: 37980345 PMC: 10657421. DOI: 10.1038/s41467-023-42695-4.

Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies.

Di Vincenzo F, Yadid Y, Petito V, Emoli V, Masi L, Gerovska D Cells. 2023; 12(15).

PMID: 37566032 PMC: 10417561. DOI: 10.3390/cells12151953.

References

Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y . Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol. 2003; 171(6):3154-62. DOI: 10.4049/jimmunol.171.6.3154. View

Ewald S, Lee B, Lau L, Wickliffe K, Shi G, Chapman H . The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature. 2008; 456(7222):658-62. PMC: 2596276. DOI: 10.1038/nature07405. View

Stott K, Tang G, Lee K, Thomas J . Structure of a complex of tandem HMG boxes and DNA. J Mol Biol. 2006; 360(1):90-104. DOI: 10.1016/j.jmb.2006.04.059. View

Barrat F, Meeker T, Gregorio J, Chan J, Uematsu S, Akira S . Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005; 202(8):1131-9. PMC: 2213213. DOI: 10.1084/jem.20050914. View

Grove T, Hands M, Regan L . Creating novel proteins by combining design and selection. Protein Eng Des Sel. 2010; 23(6):449-55. PMC: 2865361. DOI: 10.1093/protein/gzq015. View

Favicchio R, Dragan A, Kneale G, Read C . Fluorescence spectroscopy and anisotropy in the analysis of DNA-protein interactions. Methods Mol Biol. 2009; 543:589-611. DOI: 10.1007/978-1-60327-015-1_35. View

Ehlers M, Fukuyama H, McGaha T, Aderem A, Ravetch J . TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med. 2006; 203(3):553-61. PMC: 2118244. DOI: 10.1084/jem.20052438. View

Bauer S, Kirschning C, Hacker H, Redecke V, Hausmann S, Akira S . Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A. 2001; 98(16):9237-42. PMC: 55404. DOI: 10.1073/pnas.161293498. View

Vasudevan D, Chua E, Davey C . Crystal structures of nucleosome core particles containing the '601' strong positioning sequence. J Mol Biol. 2010; 403(1):1-10. DOI: 10.1016/j.jmb.2010.08.039. View

10.

Cornelie S, Hoebeke J, Schacht A, Bertin B, Vicogne J, Capron M . Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J Biol Chem. 2004; 279(15):15124-9. DOI: 10.1074/jbc.M313406200. View

11.

Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

12.

Baumann C, Aspalter I, Sharif O, Pichlmair A, Bluml S, Grebien F . CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010; 207(12):2689-701. PMC: 2989773. DOI: 10.1084/jem.20101111. View

13.

Wagner H . The sweetness of the DNA backbone drives Toll-like receptor 9. Curr Opin Immunol. 2008; 20(4):396-400. DOI: 10.1016/j.coi.2008.06.013. View

14.

Jin M, Kim S, Heo J, Lee M, Kim H, Paik S . Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007; 130(6):1071-82. DOI: 10.1016/j.cell.2007.09.008. View

15.

Gursel I, Gursel M, Yamada H, Ishii K, Takeshita F, Klinman D . Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol. 2003; 171(3):1393-400. DOI: 10.4049/jimmunol.171.3.1393. View

16.

Yasuda K, Yu P, Kirschning C, Schlatter B, Schmitz F, Heit A . Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol. 2005; 174(10):6129-36. DOI: 10.4049/jimmunol.174.10.6129. View

17.

Sester D, Naik S, Beasley S, Hume D, Stacey K . Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J Immunol. 2000; 165(8):4165-73. DOI: 10.4049/jimmunol.165.8.4165. View

18.

Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

19.

Ashman R, Adam Goeken J, Drahos J, Lenert P . Sequence requirements for oligodeoxyribonucleotide inhibitory activity. Int Immunol. 2005; 17(4):411-20. DOI: 10.1093/intimm/dxh222. View

20.

Botos I, Segal D, Davies D . The structural biology of Toll-like receptors. Structure. 2011; 19(4):447-59. PMC: 3075535. DOI: 10.1016/j.str.2011.02.004. View